Cargando…
Serum cholinesterase associated with COVID-19 pneumonia severity and mortality
Autores principales: | Nakajima, Kento, Abe, Takeru, Saji, Ryo, Ogawa, Fumihiro, Taniguchi, Hayato, Yamaguchi, Keishi, Sakai, Kazuya, Nakagawa, Tomoki, Matsumura, Reo, Oi, Yasufumi, Nishii, Mototsugu, Takeuchi, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434637/ https://www.ncbi.nlm.nih.gov/pubmed/32822684 http://dx.doi.org/10.1016/j.jinf.2020.08.021 |
Ejemplares similares
-
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19
por: Ogawa, Fumihiro, et al.
Publicado: (2021) -
An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study
por: Ogawa, Fumihiro, et al.
Publicado: (2021) -
Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19
por: Saji, Ryo, et al.
Publicado: (2021) -
Association of obesity paradox with prognosis of veno‐venous‐extracorporeal membrane oxygenation in patients with coronavirus disease 2019
por: Honzawa, Hiroshi, et al.
Publicado: (2023) -
Does the conventional landmark help to place the tip of REBOA catheter in the optimal position? A non-controlled comparison study
por: Nakajima, Kento, et al.
Publicado: (2019)